+1 (202) 780-3397
2025: Volume 9, Issue 1
Commentary P.1-2
Revolutionizing kidney care: The role of precision nephrology and artificial intelligence
Author(s):
Tyron Harris*
DOI: DOI: 10.35841/aacnt-9.1.241
Editorial P.1-2
Advancing Personalized Renal Therapy: The Role of Biomarkers in Chronic Kidney Disease Progression
Author(s):
Larry Cowgi*
DOI: DOI: 10.35841/aacnt-9.1.242
Opinion Article P.1-2
Gut microbiome and kidney disease: Targeted therapies for diabetic nephropathy
Author(s):
Monica Suet*
DOI: DOI: 10.35841/aacnt-9.1.243
Perspective P.1-1
Emerging nephroprotective strategies: The role of extracellular vesicles in renal pathophysiology and drug development
Author(s):
Abraham Aron*
DOI: DOI: 10.35841/aacnt-9.1.244
Rapid Communication P.1-2
Advancing kidney care: The role of novel anti-fibrotic agents and telemedicine
Author(s):
Sandr Herrma*
DOI: DOI: 10.35841/aacnt-9.1.245
Short Communication P.1-2
Unraveling kidney disease at the cellular level: The role of single-cell RNA sequencing
Author(s):
David Kavanagh*
DOI: DOI: 10.35841/aacnt-9.1.246
Short Communication P.1-2
The impact of mitochondrial dysfunction on renal injury: Mechanisms and therapeutic insights
Author(s):
Jay Wish*
DOI: DOI: 10.35841/aacnt-9.1.247
Editorial P.1-1
Advancing renal health: Immune checkpoint inhibitors and gene therapy in kidney disorders
Author(s):
Siman Da*
DOI: DOI: 10.35841/aacnt-9.1.248
Perspective P.1-2
Crisper-based gene editing and anti-aging therapeutics for kidney diseases
Author(s):
Priti Meena*
DOI: DOI: 10.35841/aacnt-9.1.249
Opinion Article P.1-2
Beyond diabetes: the role of SGLT2 inhibitors in modulating oxidative stress in nephrology
Author(s):
Scott Gilbert*
DOI: DOI: 10.35841/aacnt-9.1.250